Rachael Fleurence

4.8k total citations · 2 hit papers
50 papers, 3.2k citations indexed

About

Rachael Fleurence is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rachael Fleurence has authored 50 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Economics and Econometrics, 10 papers in General Health Professions and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rachael Fleurence's work include Health Systems, Economic Evaluations, Quality of Life (24 papers), Meta-analysis and systematic reviews (7 papers) and Healthcare cost, quality, practices (5 papers). Rachael Fleurence is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (24 papers), Meta-analysis and systematic reviews (7 papers) and Healthcare cost, quality, practices (5 papers). Rachael Fleurence collaborates with scholars based in United States, United Kingdom and Netherlands. Rachael Fleurence's co-authors include Huseyin Naci, Joe V. Selby, Jeroen P. Jansen, Christopher S. Hollenbeak, Lieven Annemans, Beth Devine, Robbin Itzler, Karen Lee, Neil Hawkins and Annabel Barrett and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Rachael Fleurence

48 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1

2011 825 citations Jeroen P. Jansen, Rachael Fleurence et al. Value in Health profile →
Launching PCORnet, a national patient-centered clinical research network

2014 404 citations Rachael Fleurence, Lesley H. Curtis et al. Journal of the American Medical Informatics Association profile →

Peers

Countries citing papers authored by Rachael Fleurence

Since Specialization

Citations

This map shows the geographic impact of Rachael Fleurence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachael Fleurence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachael Fleurence more than expected).

Fields of papers citing papers by Rachael Fleurence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachael Fleurence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachael Fleurence. The network helps show where Rachael Fleurence may publish in the future.

Co-authorship network of co-authors of Rachael Fleurence

This figure shows the co-authorship network connecting the top 25 collaborators of Rachael Fleurence. A scholar is included among the top collaborators of Rachael Fleurence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachael Fleurence. Rachael Fleurence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Systematic Review of Augmentation Strategies for Patients with Major Depressive Disorder 2025 ·Psychopharmacology Bulletin ·Rachael Fleurence, Rebecca Williamson, Yonghua Jing, Edward Kim, Quynh-Van Tran, (unknown), Michael E. Thase	2
2	A Taxonomy of Generative Artificial Intelligence in Health Economics and Outcomes Research: An ISPOR Working Group Report 2025 ·Value in Health ·Rachael Fleurence, Xiaoyan Wang, Jiang Bian, Mitchell K. Higashi, Turgay Ayer, Hua Xu, Dalia Dawoud, Jagpreet Chhatwal	1
3	Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations: An ISPOR Working Group Report 2024 ·Value in Health ·Rachael Fleurence, Jiang Bian, Xiaoyan Wang, Hua Xu, Dalia Dawoud, (unknown), Jagpreet Chhatwal	7
4	Experiences of Health Departments on Community Engagement and Implementation of a COVID-19 Self-testing Program 2022 ·Journal of Public Health Management and Practice ·(unknown), (unknown), Libby Horter, Rachael Fleurence, (unknown), Krishna Juluru, (unknown), (unknown), Jessica N. Ricaldi, Diana Valencia	4
5	Launching PCORnet, a national patient-centered clinical research network breakdown → 2014 ·Journal of the American Medical Informatics Association ·Rachael Fleurence, Lesley H. Curtis, Robert M. Califf, Robert W. Platt, Joe V. Selby, Jeffrey S. Brown	404
6	Engaging Patients and Stakeholders in Research Proposal Review: The Patient-Centered Outcomes Research Institute 2014 ·Annals of Internal Medicine ·Rachael Fleurence, Laura P. Forsythe, Michael S. Lauer, Jason Rotter, John P. A. Ioannidis, Anne C. Beal, Lori Frank, Joseph V. Selby	55
7	The Patient-centered Outcomes Research Institute’s Role in Advancing Methods for Patient-centered Outcomes Research 2014 ·Medical Care ·Rachael Fleurence, Danielle Whicher, Kelly M. Dunham, Jason Gerson, Robin Newhouse, Bryan R. Luce	22
8	Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials 2013 ·QJM ·Huseyin Naci, Jasper J. Brugts, Rachael Fleurence, A. E. Ades	31
9	Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1 breakdown → 2011 ·Value in Health ·Jeroen P. Jansen, Rachael Fleurence, Beth Devine, Robbin Itzler, Annabel Barrett, Neil Hawkins, Karen Lee, Cornelis Boersma, Lieven Annemans, Joseph C. Cappelleri	825
10	Economic Analysis of Decitabine Versus Best Supportive Care in the Treatment of Intermediate- and High-Risk Myelodysplastic Syndromes From a US Payer Perspective 2010 ·Clinical Therapeutics ·Feng Pan, Siyang Peng, Rachael Fleurence, (unknown), Kevin Knopf, Edward Kim	23
11	Does the Funding Source Influence the Results in Economic Evaluations? 2010 ·PharmacoEconomics ·Rachael Fleurence, Eldon Spackman, Christopher S. Hollenbeak	17
12	Economic Outcomes Associated With Atypical Antipsychotics in Bipolar Disorder 2007 ·The Primary Care Companion to The Journal of Clinical Psychiatry ·Rachael Fleurence, Mary Lou Chatterton, Julia Dixon, (unknown)	8
13	Review of the economic and quality-of-life burden of cervical human papillomavirus disease 2007 ·American Journal of Obstetrics and Gynecology ·Rachael Fleurence, Julia Dixon, Tsveta Milanova, Kathleen Beusterien	49
14	Rates and Probabilities in Economic Modelling 2007 ·PharmacoEconomics ·Rachael Fleurence, Christopher S. Hollenbeak	161
15	Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature 2005 ·Osteoporosis International ·Rachael Fleurence, Cynthia P Iglesias, David Torgerson	39
16	Cost-effectiveness of pressure-relieving devices for the prevention and treatment of pressure ulcers 2005 ·International Journal of Technology Assessment in Health Care ·Rachael Fleurence	24
17	Setting priorities for research 2004 ·Health Policy ·Rachael Fleurence, David Torgerson	61
18	Cost-effectiveness of fracture prevention treatments in the elderly 2004 ·International Journal of Technology Assessment in Health Care ·Rachael Fleurence	26
19	Issues in the economic evaluation of treatments for menopausal symptoms 2001 ·The Journal of the British Menopause Society ·Rachael Fleurence	1
20	Issues in the Economic Evaluation of Treatments for Menopausal Symptoms 2001 ·The Journal of the British Menopause Society ·Rachael Fleurence	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact